These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8652724)

  • 1. Treatment and prophylaxis of Mycobacterium avium complex.
    Young LS
    Int J STD AIDS; 1996; 7 Suppl 1():23-7. PubMed ID: 8652724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin in the prophylaxis of opportunistic infections in AIDS.
    McCutchan JA
    Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV.
    Uthman MM; Uthman OA; Yahaya I
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
    Wright J
    Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
    Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
    HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS.
    Scharfstein JA; Paltiel AD; Weinstein MC; Seage GR; Losina E; Craven DE; Freedberg KA
    Int J Technol Assess Health Care; 1999; 15(3):531-47. PubMed ID: 10874380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium avium intracellulare infection in patients with HIV or AIDS.
    Brettle RP
    J Antimicrob Chemother; 1997 Aug; 40(2):156-60. PubMed ID: 9301979
    [No Abstract]   [Full Text] [Related]  

  • 11. MAC prophylaxis revisited.
    Torres G
    GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress report: prophylaxis and therapy for MAC.
    Currier J
    AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antivirals key to MAC prevention regimen.
    AIDS Alert; 1996 Sep; 11(9):101-3. PubMed ID: 11363722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
    Dautzenberg B
    Drugs; 1997; 54 Suppl 2():1-7; discussion 28-9. PubMed ID: 9358194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in prevention and treatment of MAC.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):11. PubMed ID: 11363104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-benefit assessment of therapies for Mycobacterium avium complex infections.
    Griffith DE
    Drug Saf; 1999 Aug; 21(2):137-52. PubMed ID: 10456381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.
    Dunne M; Fessel J; Kumar P; Dickenson G; Keiser P; Boulos M; Mogyros M; White AC; Cahn P; O'Connor M; Lewi D; Green S; Tilles J; Hicks C; Bissett J; Schneider MM; Benner R
    Clin Infect Dis; 2000 Nov; 31(5):1245-52. PubMed ID: 11073759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.